
UroGen Pharma Grants Inducement RSUs to 14 New Employees

I'm PortAI, I can summarize articles.
UroGen Pharma Ltd. has granted inducement restricted stock units (RSUs) to 14 new employees, with up to 32,500 ordinary shares issuable upon vesting. The RSUs will vest equally over three years, contingent on continued employment. This announcement was published via GlobeNewswire on December 05, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

